Skip to content

Efficacy and Safety of Modified Radical Resection for Moderate-to-Severe Hidradenitis Suppurativa of Buttocks: A Retrospective Study

Efficacy and Safety of Modified Radical Resection for Moderate-to-Severe Hidradenitis Suppurativa of Buttocks: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110176
Enrollment
Unknown
Registered
2025-10-09
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidradenitis Suppurativa

Interventions

observation group:None

Sponsors

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age greater than or equal to 18 years old. 2. The clinical severity of HS is moderate-severe (Hurley stage II-III) and the skin lesion is affected by the buttocks. 3. Diagnosed with HS by histopathological examination of the Department of Pathology of our hospital. 4. HS patients who underwent modified radical resection in the Department of Dermatology at our hospital. 5. Patients with a follow-up time of at least 12 months and complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Patients who are lost to follow-up. 2. Patients with a follow-up time of less than 12 months. 3. Patients with non-hip HS (even if modified radical resection) have undergone modified radical resection.

Design outcomes

Primary

MeasureTime frame
Hidradenitis Suppurativa Clinical Response;

Secondary

MeasureTime frame
Dermatology Life Quality Index;Recurrence rate;

Countries

China

Contacts

Public ContactBu wenbo

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College

19943909917@163.com+86 150 0515 7051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026